STERIS Profit Margin 2010-2022 | STE
Current and historical gross margin, operating margin and net profit margin for STERIS (STE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. STERIS net profit margin as of September 30, 2022 is -0.17%.
|STERIS Annual Profit Margins
|STERIS Quarterly Profit Margins
||Medical Instruments Manufacturing
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.